Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be Presented at the Upcoming IASLC 2023 World Conference of Lung Cancer
August 16, 2023 10:56 ET | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
TIP_link_300x300.jpg
8.2% CAGR for Lung Cancer Screening Market Worth $4.36Bn by 2030 with NSCLC Segment (8% CAGR) Driving Growth During 2022-2030 | The Insight Partners
July 06, 2023 10:08 ET | The Insight Partners
Pune, India, July 06, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Lung Cancer Screening Market Size Report and Forecast to 2030 - COVID-19 Impact and...
Research Nester Logo.jpg
Cancer Biomarkers Market revenue to cross USD 33 Billion by 2033, says Research Nester
July 05, 2023 08:11 ET | Research Nester
New York, July 05, 2023 (GLOBE NEWSWIRE) -- The global cancer biomarkers market is estimated to grow at a CAGR of ~14% from 2023 to 2033. The market is estimated to garner a revenue of nearly USD 33...
researchdrivelogo.jpg
Global Cancer Stem Cells Market Predicted to Register a Revenue of $1,722.7 Million and Grow at a CAGR of 10.3% Over the Estimated Timeframe 2019-2026 [180-Pages] | Released by Research Dive
April 12, 2023 09:02 ET | Research Dive
New York, USA, April 12, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research dive, the global cancer stem cells market is anticipated to garner $1,722.7 million in revenue and rise...
Fibrogen_US_Primary_logo_RGB_M01.jpg
FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-2, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis
April 03, 2023 07:00 ET | FibroGen, Inc.
- 372 IPF Patients Enrolled -- Topline Data Anticipated Mid-2024 - SAN FRANCISCO, April 03, 2023 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the completion of patient...
Dr. Raymond Osarogiagbon
Baptist Cancer Center research proves incidental lung nodule program effective in detecting cancer early
March 09, 2023 08:00 ET | Baptist Memorial Health Care
Memphis, TN, March 09, 2023 (GLOBE NEWSWIRE) -- Memphis-based Baptist Cancer Center published a JAMA Network Open article proving the effectiveness of incidental lung nodule, or tumor, programs in...
Immuneering-logo (1).png
Immuneering Presents Preclinical Data with Lead Program IMM-1-104 Supporting Universal-RAS Activity
March 05, 2023 18:30 ET | Immuneering Corporation
Broad response demonstrated through deep cyclic inhibition of MAPK pathway, independent of specific RAS mutation Phase 1/2a clinical trial with IMM-1-104 underway in patients with advanced solid...
nsCanary™ Featured on AGA Shark Tank
NovaScan’s nsCanary™ Tech Platform Named One of Five Finalists in AGA’s Shark Tank Competition
March 02, 2023 10:00 ET | NovaScan
Chicago, IL, March 02, 2023 (GLOBE NEWSWIRE) -- NovaScan, a clinical stage oncology company, has been selected by the American Gastroenterological Association (AGA) as a finalist in its annual Shark...
Vantage Market Research.png
Cancer Biomarkers Market to Hit USD 31.8 Billion by 2028 | Cancer Biomarkers Industry CAGR 17.5% During 2022-2028; Exclusive Insight Report by Vantage Market Research
May 29, 2022 22:13 ET | Vantage Market Research
WASHINGTON, May 29, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Cancer Biomarkers Market finds that the rise in prevalence of various types of cancers such as...
Straits Research Pvt Ltd
Global Cancer Stem Cells Market is Expected to Reach USD 5.6 Billion by 2030, at a CAGR of 15.8%: Straits Research
May 11, 2022 12:30 ET | Straits Research
New York, United States, May 11, 2022 (GLOBE NEWSWIRE) -- The Global market for cancer stem cells is expected to grow from $ 1.8 Billion in 2021 to $5.6 Billion by 2030, at a compound annual growth...